What's new

Orphan designation: Arsenic trioxide Treatment of acute promyelocytic leukaemia, 13/12/2024 Positive

Orphan designation: Arsenic trioxide Treatment of acute promyelocytic leukaemia, 13/12/2024 Positive

Feb 24, 2025 - 10:35
 0
Orphan designation: Arsenic trioxide Treatment of acute promyelocytic leukaemia, 13/12/2024 Positive
Orphan designation: Arsenic trioxide Treatment of acute promyelocytic leukaemia, 13/12/2024 Positive
Read More

Tags:

Previous Article

STAT+: Fueled by pandemic frustrations, populist parties are embracing anti-vacc...

Next Article

New World wines gain ground at Wine Paris 2025

Related Posts

Overview of comments received on `Nilotinib hard capsul...

Feb 12, 2025  0

Human medicines European public assessment report (EPAR): Wainzua, eplontersen, Date of authorisation: 06/03/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 12, 2025  0

Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 64, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 16, 2025  0